BestaMed is a parallel distributor of original medicines, medical devices and food supplements with proven and verified origin.
Our expertise is broad and covers strategic distribution solutions for medicinal products, medical devices and food supplements.
We advise and create tailored solutions to maximally quickly and efficiently achieve the marketing and business goals of our partners.
Modern logistics center in Sofia and a fleet of 28 vehicles, 6 of which with temperature control systems.
Our customers, our local community, our suppliers and partners share our values and work with the care of society and the environment. That is of paramount importance to us.
BetstaMed is a licensed wholesaler and Marketing Authorization Holder for parallel import. We are a Certified Partner that meets the requirements of Good Distribution Practice and successfully undergoes the Quality Management Audit processes by TUV and RINA. We are an Organization with a Quality Management System certified by RINA under ISO 9001: 2015.
BestaMed is an officially licensed by BDA as a wholesaler of medicinal products and medical devices.
425 Tzarigradsko shose blvd.
building 1 (Gates 43-44)
1137 Sofia, Bulgaria
+359.2.421.0829; +359.2.442.6262
Who we collaborate with in social benefit
The Bulgarian Association for Medicine Parallel Trade Development (BAMPTD )is an organization representing companies with a mission to ensure the access of Bulgarian patients to quality and effective medicinal products on time and in full volume.
Affordable Medicines Europe (AME is the new name of EAEPC) is a non-profit organization in Brussels, which unites the licensed European pharmaceutical parallel distribution industry, supporting the achievements of the industry and the benefits of its products.
The Bulgarian Medicines Verification Organization is a non-profit organization to support the implementation in Bulgaria of Directive 2011/62 / EU on the prevention of the entry of counterfeit medicines into the legal supply chain.
Who is BetamaMed a representative for the pharma market in Bulgaria?